Brunel University Research Archive(BURA) preserves and enables easy and open access to all
types of digital content. It showcases Brunel's research outputs.
Research contained within BURA is open access, although some publications may be subject
to publisher imposed embargoes. All awarded PhD theses are also archived on BURA.
Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/28005Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Gurgula, O | - |
| dc.date.accessioned | 2024-01-11T18:20:19Z | - |
| dc.date.available | 2024-01-11T18:20:19Z | - |
| dc.date.issued | 2023-11-27 | - |
| dc.identifier.citation | Gurgula, O. (2023) 'The new EU compulsory licensing regime needs to allow the export of medicines', Medicines Law & Policy, 23 November, pp. 1 - 2. Available at: https://medicineslawandpolicy.org/2023/11/the-new-eu-compulsory-licensing-regime-needs-to-allow-the-export-of-medicines/ (accessed: 11 January 2024). | en_US |
| dc.identifier.uri | https://bura.brunel.ac.uk/handle/2438/28005 | - |
| dc.description.abstract | A war-weary Ukraine critically depends on the support of the European Union (EU) in all spheres, especially in the provision of life-saving medicines to the Ukrainian population. The EU has pledged its support for Ukraine following Russia’s invasion. However, a recent proposal by the European Commission on a new EU-wide compulsory licensing regime (COM(2023) 224) may have the opposite effect. | en_US |
| dc.format.extent | 1 - 2 | - |
| dc.format.medium | Electronic | - |
| dc.language.iso | en | en_US |
| dc.publisher | Medicines Law & Policy | en_US |
| dc.relation.uri | https://medicineslawandpolicy.org/2023/11/the-new-eu-compulsory-licensing-regime-needs-to-allow-the-export-of-medicines/ | - |
| dc.rights | Copyright © The Author 2023. This work is licensed under Creative Commons (https://creativecommons.org/licenses/by-nc-nd/4.0/). You are free to share, with attribution and without changes, for non-commercial purposes. | - |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
| dc.title | The new EU compulsory licensing regime needs to allow the export of medicines | en_US |
| dc.type | Other | en_US |
| pubs.publication-status | Published | - |
| dc.rights.holder | The Author | - |
| Appears in Collections: | Brunel Law School Research Papers | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| FullText.pdf | 1.57 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
